Optimising multi pronged drug intercepts in AMD

---

Review Article

Author Details : Sunil Chaudhry*

Volume : 7, Issue : 2, Year : 2020

Article Page : 64-72

https://doi.org/10.18231/j.agems.2020.010

Suggest article by email

Get Permission

---

Abstract

Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly population worldwide. The clinical spectrum of AMD comprises of drusen, hyperplasia of the retinal pigment epithelium (RPE), atrophy and choroidal neovascularization (CNV). These changes affect the macula of the retina and subsequently may affect central or reading visual acuity. The pharmacological therapies include photodynamic therapy (PDT), steroids, vascular endothelial growth factor (VEGF) inhibitors, extracellular matrix(ECM) modifiers, gene therapy and nutrition supplements.

Keywords: Agerelated macular degeneration (AMD), ie2 (Tyrosineprotein kinase) anti VEGF ranibizumab bevacizumab aflibercept.

How to cite : Chaudhry S , Optimising multi pronged drug intercepts in AMD. Ann Geriatr Educ Med Sci 2020;7(2):64-72

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.